Tiger Brokers

HK StockDetailed Quotes
Provided by Tiger Trade Technology Pte. Ltd.

CSTONE PHARMA-B

5.330
+0.1903.70%
Volume:7.33M
Turnover:39.09M
Market Cap:7.87B
PE:-74.58
High:5.410
Open:5.170
Low:5.140
Close:5.140
52wk High:13.150
52wk Low:2.030
Shares:1.48B
HK Float Shares:1.48B
Volume Ratio:1.98
T/O Rate:0.50%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.071
ROE:-96.36%
ROA:-16.93%
PB:22.07
PE(LYR):-74.58
PS:34.34

Loading ...

OverviewCompanyNewsFilings

Company Profile

Company Name:
CSTONE PHARMA-B
Exchange:
SEHK
Establishment Date:
2015
Employees:
131
Office Location:
C1 Building,No. 218 Xinghu Street,North Block,Suzhou Industrial Park,Suzhou,Jiangsu Province,China
Website:
http://www.cstonepharma.com
Zip Code:
215123
Phone:
86 512 8718 6550
Fax:
- -
Introduction:
CStone Pharmaceuticals is an investment holding company primarily engaged in the research and development of therapies for oncology, autoimmune and inflammation, and other key disease areas. Through its subsidiaries, the Company is primarily engaged in the research and development of biopharmaceutical products, the sales of pharmaceutical products, as well as the provision of license of its intellectual property (IP) or commercialization license. The Company’s products primarily include targeted therapies, AYVAKIT (avapritinib), GAVRETO (pralsetinib) and CEJEMLY (sugemalimab). The Company is also engaged in the development and commercialization of immuno-oncology. The Company primarily conducts its businesses in the domestic market and overseas markets, such as Central and Eastern Europe and Switzerland.

Directors

Name
Position
LI Wei
Chairman of the Board,Director,Member of the Remuneration and Assessment Committee,Chairman of the Nomination Committee
Jason Yang
Executive Director,Chairman of the Strategic and Development Committee
Kenneth Howard Jarrett
Independent Director,Member of the Strategic and Development Committee,Audit Committee Member
Fang Xie
Independent Director,Member of the Remuneration and Assessment Committee,Member of the Nomination Committee,Investment Decision Committee Member,Audit Committee Chairman
YAN Jia Xun
Independent Director,Chairman of the Remuneration and Assessment Committee,Member of the Nomination Committee,Audit Committee Member
Edward Hu
Director,Member of the Strategic and Development Committee,Investment Decision Committee Chairman
Kenneth Walton Hitchner III
Director,Investment Decision Committee Member

Shareholders

Name
Position
Jason Yang
CEO,Other Senior Executives
SHI Qing Mei
Vice General Manager,Other Senior Executives
ZHANG Ying Hua
Vice General Manager,Other Senior Executives
NI Wei Cong
CFO,Board Secretary,Corporate Secretary
LA Yu Juan
Other Senior Executives
Michael J. Choi
Other Senior Executives